Treatment of Plantar Warts

Phase 3UnknownNCT05198180

Sohag University60 enrolled

Overview

This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Plantar Wart

Interventions

Topical 30%Potassium hydroxide solutionDRUG

Patients will apply the solution every day under occlusion for 3 months

Topical 45% hydrogen peroxide solutionDRUG

Patients will apply the solution every day under occlusion

Eligibility

Sex: ALLMin age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * confirmed diagnosis by clinical and dermoscopic examination of plantar warts Exclusion Criteria: * history of hypersensitivity to any component used in this study * pregnancy and breastfeeding * patients who receive immune suppressive therapy * patients who received any wart treatments during the last 2 months before enrollent in the study * patients who refused participation in the study

Locations (1)

Sohag faculty of medicine

Sohag, Egypt

Outcomes

Primary Outcomes

Change in the size of the plantar warts

Decrease in the size of warts measured by a ruler

Time frame: 12 weeks after end of treatment

Central Contacts

Samar Sa Ahmed, Resident

CONTACT

01152471005 Summersayed156@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.